BioFinlandin jäsen

Admescope is a contract research organisation (CRO) providing the tailor made ADME-Tox services to drug discovery companies in 28 countries on four continents.

The service offering is widely spread over the whole ADME-Tox area with top-notch expertise in drug metabolism, drug-drug interactions, pharmacokinetics and quantitative bioanalysis. The right assays always available, whether in the discovery, lead optimisation or preclinical development phase. The level of data interpretation can be customised according to customer preferences.

In addition to small molecules and peptides Admescope provides services also for larger molecules.

Service Offering:

- In vitro Metabolism
- In vivo DMPK
- Drug Interactions
- Quantitative Bioanalysis
- Permeability and Transporters
- Physicochemistry and - -- Binding
- In vitro Toxicology
Biologics